Author

Martin Oaks

Unknown affiliation - Cited by 1,369

Biography

Transplant Research Laboratory, Aurora St. Luke’s Medical Center, Milwaukee, WI, USA . he has specialities in oncology,crdiac transplant, cancer researcher, therapeutic nanoparticles. he has done so many research work regarding cancer .
Title
Cited by
Year
A native soluble form of CTLA-4
MK Oaks, KM Hallett, RT Penwell, EC Stauber, SJ Warren, AJ TectorCellular immunology 201 (2), 144-153, 2000200
321
2000
Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease
MK Oaks, KM HallettThe Journal of Immunology 164 (10), 5015-5018, 2000200
291
2000
Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population
C Lei, Z Dongqing, S Yeqing, MK Oaks, C Lishan, J Jianzhong, Q Jie, ...European journal of human genetics 13 (7), 823-828, 2005200
131
2005
Adrenocortical responses to ACTH in neonatal rats: effect of hypoxia from birth on corticosterone, StAR, and PBR
H Raff, JJ Hong, MK Oaks, EP WidmaierAmerican Journal of Physiology-Regulatory, Integrative and Comparative …, 2003200
58
2003
Hypoxia in vivo inhibits aldosterone synthesis and aldosterone synthase mRNA in rats
H Raff, BM Jankowski, WC Engeland, MK OaksJournal of applied physiology 81 (2), 604-610, 1996199
50
1996
Differential inhibition of autoreactive memory-and alloreactive naive T cell responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y
VAL Huurman, WWJ Unger, BPC Koeleman, MK Oaks, AK Chandraker, ...Clinical & Experimental Immunology 150 (3), 487-493, 2007200
42
2007
37
1995
Vaccination in multiple myeloma: review of current literature
A Alemu, JO Richards, MK Oaks, MA ThompsonClinical Lymphoma Myeloma and Leukemia 16 (9), 495-502, 2016201
34
2016
Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation
M Oaks, K Michel, NZ Sulemanjee, V Thohan, FX DowneyThe Journal of Heart and Lung Transplantation 33 (7), 713-720, 2014201
28
2014
CTLA-4 is important in maintaining long-term survival of cardiac allografts
A Chandraker, V Huurman, K Hallett, X Yuan, AJ Tector, CH Park, E Lu, ...Transplantation 79 (8), 897-903, 2005200
25
2005
Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms
A Berry, M Tector, MK OaksJournal of negative results in biomedicine 7 (1), 1-4, 2008200
22
2008
Flow cytometry assessment of residual melanoma cells in tumor‐infiltrating lymphocyte cultures
JO Richards, J Treisman, N Garlie, JP Hanson, MK OaksCytometry Part A 81 (5), 374-381, 2012201
18
2012
Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination
N Chinnasamy, JS Treisman, MK Oaks, JP Hanson, D ChinnasamyGene therapy 12 (3), 259-271, 2005200
16
2005
15
2018
Biochemical analysis of CTLA-4 immunoreactive material from human blood
M Tector, BO Khatri, K Kozinski, K Dennert, MK OaksBMC immunology 10, 1-9, 2009200
14
2009
Many de novo donor‐specific antibodies recognize β2‐microglobulin‐free, but not intact HLA heterodimers
K Michel, R Santella, J Steers, A Sahajpal, FX Downey, V Thohan, ...Hla 87 (5), 356-366, 2016201
14
2016
Alloimmune induction of endothelial cell-derived interferon-γ–inducible chemokines1
R Raju, A Malloy, T Shah, R Smith, M Oaks, JD HosenpudTransplantation 75 (7), 1072-1074, 2003200
12
2003